Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Sign...

por Qiang, Shi Qing, Qin, Gao Chao, Jing, Li, Qiang, Feng Zi, Mei, Qin Hong, Long, Chen Di
Publicado 2021